2,392 reports of this reaction
4.5% of all DESVENLAFAXINE SUCCINATE reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for DESVENLAFAXINE SUCCINATE, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 2,392 FDA adverse event reports linking DESVENLAFAXINE SUCCINATE to NAUSEA. This represents approximately 4.5% of all 53,036 adverse event reports for this drug.
Patients taking DESVENLAFAXINE SUCCINATE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among DESVENLAFAXINE SUCCINATE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for DESVENLAFAXINE SUCCINATE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 2,392 FDA reports for DESVENLAFAXINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 4.5% of all adverse event reports for DESVENLAFAXINE SUCCINATE, making it one of the most commonly reported side effect.
If you experience nausea while taking DESVENLAFAXINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.